BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29625472)

  • 1. Visual Cortex Activation in Patients With Stargardt Disease.
    Melillo P; Prinster A; Di Iorio V; Olivo G; D'Alterio FM; Cocozza S; Orrico A; Quarantelli M; Testa F; Brunetti A; Simonelli F
    Invest Ophthalmol Vis Sci; 2018 Mar; 59(3):1503-1511. PubMed ID: 29625472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.
    Schönbach EM; Wolfson Y; Strauss RW; Ibrahim MA; Kong X; Muñoz B; Birch DG; Cideciyan AV; Hahn GA; Nittala M; Sunness JS; Sadda SR; West SK; Scholl HPN;
    JAMA Ophthalmol; 2017 Jul; 135(7):696-703. PubMed ID: 28542693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full-field ERG as a predictor of the natural course of
    Schroeder M; Kjellström U
    Mol Vis; 2018; 24():1-16. PubMed ID: 29386879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete cortical reorganization in macular degeneration.
    Liu T; Cheung SH; Schuchard RA; Glielmi CB; Hu X; He S; Legge GE
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6826-34. PubMed ID: 20631240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correspondence between retinotopic cortical mapping and conventional functional and morphological assessment of retinal disease.
    Ritter M; Hummer A; Ledolter AA; Holder GE; Windischberger C; Schmidt-Erfurth UM
    Br J Ophthalmol; 2019 Feb; 103(2):208-215. PubMed ID: 29699983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapy.
    Testa F; Rossi S; Sodi A; Passerini I; Di Iorio V; Della Corte M; Banfi S; Surace EM; Menchini U; Auricchio A; Simonelli F
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4409-15. PubMed ID: 22661472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1).
    Burke TR; Rhee DW; Smith RT; Tsang SH; Allikmets R; Chang S; Lazow MA; Hood DC; Greenstein VC
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8006-15. PubMed ID: 21873672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration.
    Mehat MS; Sundaram V; Ripamonti C; Robson AG; Smith AJ; Borooah S; Robinson M; Rosenthal AN; Innes W; Weleber RG; Lee RWJ; Crossland M; Rubin GS; Dhillon B; Steel DHW; Anglade E; Lanza RP; Ali RR; Michaelides M; Bainbridge JWB
    Ophthalmology; 2018 Nov; 125(11):1765-1775. PubMed ID: 29884405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical phenotypes and prognostic full-field electroretinographic findings in Stargardt disease.
    Zahid S; Jayasundera T; Rhoades W; Branham K; Khan N; Niziol LM; Musch DC; Heckenlively JR
    Am J Ophthalmol; 2013 Mar; 155(3):465-473.e3. PubMed ID: 23219216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.
    Verdina T; Greenstein VC; Sodi A; Tsang SH; Burke TR; Passerini I; Allikmets R; Virgili G; Cavallini GM; Rizzo S
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1307-1317. PubMed ID: 28365912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cone photoreceptor abnormalities correlate with vision loss in patients with Stargardt disease.
    Chen Y; Ratnam K; Sundquist SM; Lujan B; Ayyagari R; Gudiseva VH; Roorda A; Duncan JL
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3281-92. PubMed ID: 21296825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macular function and morphologic features in juvenile stargardt disease: longitudinal study.
    Testa F; Melillo P; Di Iorio V; Orrico A; Attanasio M; Rossi S; Simonelli F
    Ophthalmology; 2014 Dec; 121(12):2399-405. PubMed ID: 25097154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
    Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
    Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
    Sisk RA; Leng T
    Retina; 2014 Aug; 34(8):1567-75. PubMed ID: 24743636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt Disease.
    Melillo P; Testa F; Rossi S; Di Iorio V; Orrico A; Auricchio A; Simonelli F
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT247-52. PubMed ID: 27409479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Changes of Fixation Location and Stability Within 12 Months in Stargardt Disease: ProgStar Report No. 12.
    Schönbach EM; Strauss RW; Kong X; Muñoz B; Ibrahim MA; Sunness JS; Birch DG; Hahn GA; Nasser F; Zrenner E; Sadda SR; West SK; Scholl HPN;
    Am J Ophthalmol; 2018 Sep; 193():54-61. PubMed ID: 29890160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic characteristics of late-onset Stargardt's disease.
    Westeneng-van Haaften SC; Boon CJ; Cremers FP; Hoefsloot LH; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Jun; 119(6):1199-210. PubMed ID: 22449572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric Inter-Eye Progression in Stargardt Disease.
    Lambertus S; Bax NM; Groenewoud JM; Cremers FP; van der Wilt GJ; Klevering BJ; Theelen T; Hoyng CB
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6824-6830. PubMed ID: 28002570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of dark-adapted visual function with retinal structural changes in patients with Stargardt disease.
    Salvatore S; Fishman GA; McAnany JJ; Genead MA
    Retina; 2014 May; 34(5):989-95. PubMed ID: 24280667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption in Bruch membrane in patients with Stargardt disease.
    Park SP; Chang S; Allikmets R; Smith RT; Burke TR; Gregory-Roberts E; Tsang SH
    Ophthalmic Genet; 2012 Mar; 33(1):49-52. PubMed ID: 22060670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.